Accelerating the Timeline to First-in-human Trials

Presented by

David Edwards, Capsugel; Tim Scott, Pharmatek Laboratories; Joseph Forth, AMRI

About this talk

Accelerating the Timeline to First-in-human Trials: NEW Case Studies on API in Capsule Technology Accurately and precisely dispensing drug substances alone, in tiny amounts as low as 100 micrograms into capsules, excipients or bulking agents is changed the process of drug development. Today, Pharma companies use micro-dosing technology to shorten drug development by reducing the need for costly time-consuming stability and pre-formulation studies. Reducing the time it takes to reach the critical "first in human" clinical decision point allows an increase in throughput of candidate compounds for development, thereby enabling pharma development departments to focus their resources on potential winners. This webinar will feature NEW case studies on the Capsugel technology. Speakers include: David Edwards, Director of Pharmaceutical Technology, Capsugel Tim Scott, President, Pharmatek Laboratories Joseph Forth, Manager, Pharmaceutical Development AMRI

Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (21)
Subscribers (4828)
This channel will provide webinars that focus on the unique niche of post-discovery development and validation as well as webinars that examine current products, technologies. and philosophies used in laboratories; tracks the deployment of tools that processors and the food service industry professionals use to ensure safe and consistent products.